AAP Grand Rounds Subscribe to Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 12 No. 3, September 2004
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pate, B. M.
Right arrow Articles by Jackson, M. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pate, B. M.
Right arrow Articles by Jackson, M. A.
Related Collections
Right arrow Infectious Diseases
Right arrow Pulmonology
Right arrow Hospital Care

AAP Grand Rounds 12:28-29 (2004)
© 2004 American Academy of Pediatrics

HOSPITAL CARE

Etiology of Community-Acquired Pneumonia in Hospitalized Pediatric Patients

Source: Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113:701–707.[Abstract/Free Full Text]

The first 20% of the full text of this article appears below.

The precise etiology of lower respiratory infections (LRIs) in children remains poorly defined because efforts to identify the causative agent in LRIs among children have produced inconsistent results. The authors from the University of Texas Southwestern in Dallas, the University of Alabama in Birmingham, and the National Public Health Institute in Helsinki, Finland, conducted a prospective study of community-acquired pneumonia (CAP) among 184 consecutive children hospitalized for LRI over a 14-month period at a single Dallas children’s hospital. Children were eligible for enrollment if they were immunocompetent, 6 weeks to 18 years of age, had preceding fever, and had clinical (tachypnea, chest retractions, or abnormal auscultatory findings on chest exam) and radiologic evidence of LRI. Children with uncomplicated bronchiolitis were excluded. No child had received pneumococcal conjugate or polysaccharide vaccines.

One hundred fifty-four children were evaluated. Radiographic interpretation was blinded to clinical and laboratory findings. Microbiologic laboratory evaluation included blood culture (89%), pleural fluid culture (21%), naso- and oropharyngeal viral culture (88%), Mantoux skin test, and serological immunoassay for Chlamydia trachomatis, C pneumoniae, Mycoplasma pneumoniae, respiratory syncytial virus (RSV), adenovirus, parainfluenza, and influenza. In addition, white blood cell count (WBC) and serum procalcitonin concentrations were measured in 90% and 97% of children, respectively. All patients were treated with antibiotics.

At . . . [Full Text of this Article]

Brian M. Pate, MD, FAAP1 and Mary Anne Jackson, MD, FAAP2
1 Hospitalist Services, Children’s Mercy Hospital, Kansas City, MO
2 Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO

 





HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Academy of Pediatrics.